Neurostimulation Devices Market Size

Neurostimulation Devices Market Size

Neurostimulation Devices Market was valued at USD 8.3 billion in 2022 and is projected to register more than 12.2% CAGR between 2023 and 2032. Increasing demand for minimally invasive surgery coupled with rising prevalence of neurological disorders are foremost factors propelling the market market growth.  For instance, according to the Alzheimer’s Association, in the U.S. more than 5.5 million individuals are suffering from Alzheimer’s and this number is projected to reach 16 million by 2050.

To get key market trends

  Download Free Sample

Furthermore, companies and organizations across the globe have been pumping billions into the development of unique, sophisticated, and revolutionary neurostimulation devices. For instance, in February 2021, Mainstay Medical Holdings PLC reported that it completed an equity offering proceeds of about USD 108 million. The funds were used to support and strengthen the business of ReActive8, an implanted restorative neurostimulation device, commercial launch in the U.S., thus further expanding its presence in Australia and Europe. Therefore, the abovementioned factors are estimated to augment neurotech devices market growth, which is estimated to account for USD 42.1 billion by 2032.